Verastem Inc. (United States) is listed on the Nasdaq and has a market capitalization of $670.69 million, with shareholders equity totaling $10.10 million.
The company employs approximately 102 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Verastem Inc. reported $100.30 million in revenue, generating net income of $-178.90 million.
Key financial metrics include a P/E ratio of -3.75, a price-to-book (P/B) ratio of 66.40, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker VSTM.